Estimation of radiation doses for atomic-bomb survivors in the Hiroshima University Registry

Hoshi, M; Matsuura, M; Hayakawa, N; Kamada, N; Ito, C

doi:10.1097/00004032-199605000-00017

Title: Estimation of radiation doses for atomic-bomb survivors in the Hiroshima University Registry

Full Record
Other Related Research

Abstract

The present study presents the Hiroshima University Registry of atomic bomb survivors, of which the total number is about 270,000, and application of absorbed doses. From this registry, we picked up 49,102 survivors and applied organ doses based on the dosimetry system 1986 (DS86), which is named the Atomic Bomb Survivor 1993 Dose (ABS93D). The applied dose data are based on the tables listed in the DS86 final report such as the free-in-air kermas, the house shielding factors, and organ dose factors for the active bone marrow and the breast. Calculations for the 13 other organs provided in DS86 are possible. To obtained the organ doses for each survivor, it is necessary to obtain information concerning (1) place exposed, (2) whether they were shielded or not, and (3) age. ABS93D body transmission factors for active bone marrow for neutrons and gamma rays agreed with DS 86 to within a few percent. Of the survivors studied, 35, 123 of them were used for the relative risk estimation of leukemia mortality, adopting the same method as the Radiation Effects Research Foundation (RERF) for comparison. For the observation period from 1968 to 1989, the analyzed relative risks for leukemia mortality at 1 Gymore »« less

Authors:

Hoshi, M; Matsuura, M; Hayakawa, N; Kamada, N ^[1]; Ito, C ^[2]

Hiroshima Univ., Kasumi (Japan)
Hiroshima A-bomb Casualty Council Health Management Promotion Center, Senda-machi Naka-ku (Japan)

Publication Date:: Wed May 01 00:00:00 EDT 1996

Sponsoring Org.:: USDOE

OSTI Identifier:: 283167

Resource Type:: Journal Article

Journal Name:: Health Physics

Additional Journal Information:: Journal Volume: 70; Journal Issue: 5; Other Information: PBD: May 1996

Country of Publication:: United States

Language:: English

Subject:: 56 BIOLOGY AND MEDICINE, APPLIED STUDIES; A-BOMB SURVIVORS; RADIATION DOSES; BODY; BONE MARROW; DOSIMETRY; HIROSHIMA; LEUKEMIA; MORTALITY

Citation Formats


                    Hoshi, M, Matsuura, M, Hayakawa, N, Kamada, N, and Ito, C. Estimation of radiation doses for atomic-bomb survivors in the Hiroshima University Registry.  United States: N. p., 1996. 
        Web.  doi:10.1097/00004032-199605000-00017.

Copy to clipboard


                    Hoshi, M, Matsuura, M, Hayakawa, N, Kamada, N, & Ito, C. Estimation of radiation doses for atomic-bomb survivors in the Hiroshima University Registry.  United States.  https://doi.org/10.1097/00004032-199605000-00017

Copy to clipboard


                    Hoshi, M, Matsuura, M, Hayakawa, N, Kamada, N, and Ito, C. 1996.  
        "Estimation of radiation doses for atomic-bomb survivors in the Hiroshima University Registry".  United States.  https://doi.org/10.1097/00004032-199605000-00017.

Copy to clipboard


                    
@article{osti_283167,

  title        = {Estimation of radiation doses for atomic-bomb survivors in the Hiroshima University Registry},

  author       = {Hoshi, M and Matsuura, M and Hayakawa, N and Kamada, N and Ito, C},

  abstractNote = {The present study presents the Hiroshima University Registry of atomic bomb survivors, of which the total number is about 270,000, and application of absorbed doses. From this registry, we picked up 49,102 survivors and applied organ doses based on the dosimetry system 1986 (DS86), which is named the Atomic Bomb Survivor 1993 Dose (ABS93D). The applied dose data are based on the tables listed in the DS86 final report such as the free-in-air kermas, the house shielding factors, and organ dose factors for the active bone marrow and the breast. Calculations for the 13 other organs provided in DS86 are possible. To obtained the organ doses for each survivor, it is necessary to obtain information concerning (1) place exposed, (2) whether they were shielded or not, and (3) age. ABS93D body transmission factors for active bone marrow for neutrons and gamma rays agreed with DS 86 to within a few percent. Of the survivors studied, 35, 123 of them were used for the relative risk estimation of leukemia mortality, adopting the same method as the Radiation Effects Research Foundation (RERF) for comparison. For the observation period from 1968 to 1989, the analyzed relative risks for leukemia mortality at 1 Gy by shielded kerm and by active bone marrow dose are 2.01 and 2.37, respectively, which are consistent with the RERF results. 11 refs., 1 fig., 3 tabs.},

  doi          = {10.1097/00004032-199605000-00017},

  url          = {https://www.osti.gov/biblio/283167},
  journal      = {Health Physics},
number       = 5,

  volume       = 70,

  place        = {United States},

  year         = {Wed May 01 00:00:00 EDT 1996},

  month        = {Wed May 01 00:00:00 EDT 1996}

}

Copy to clipboard

Journal Article:

https://doi.org/10.1097/00004032-199605000-00017

Other availability

Find in Google Scholar

Search WorldCat to find libraries that may hold this journal

Save / Share:

Export Metadata

Save to My Library

Similar records in OSTI.GOV collections:

Dose-response relationship of neutrons and. gamma. rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950--1971

Journal Article Ishimaru, T; Otake, M; Ichimaru, M - Radiat. Res.; (United States)

The incidence of leukemia during 1950 to 1971 in a fixed mortality sample of atomic bomb survivors in Hiroshima and Nagasaki was analyzed as a function of neutron and ..gamma.. kerma and marrow doses. Two dose-response models were tested for acute leukemia, chronic granulocytic leukemia, and all types of leukemia, respectively. Each model postulates that the leukemia incidence depends upon the sum of separate risks imposed by ..gamma.. and neutron doses. In Model I the risk from both types of radiation is assumed to be directly proportional to the respective doses, while Model II assumes that whereas the risk frommore »« less
https://doi.org/10.2307/3575148
Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies

Journal Article Mabuchi, Kiyohiko; Tokunaga, Masayoshi; Preston, D; ... - Radiation Research; (United States)

More than 30 years ago, population-based tumor registries were established in Hiroshima and Nagasaki. This report, the first of a series of papers on cancer incidence, describes methodological aspects of the tumor registries and discusses issues of data quality in the context of the Life Span Study (LSS) cohort, the major atomic bomb survivor population. The tumor registries in Hiroshima and Nagasaki are characterized by active case ascertainment based on abstraction of medical records at area hospitals, augmented by tissue registries operational in the area and a number of clinical and pathological programs undertaken over the years among the atomicmore »« less
https://doi.org/10.2307/3578891
Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses

Journal Article Shimizu, Y; Kato, H; Schull, W; ... - Radiation Research; (USA)

As a result of the reassessment of the A-bomb dosimetry, new (DS86) doses were calculated in 1986. In this paper, site-specific estimates of cancer mortality in the years 1950-1985, based on these new doses, are compared with those using the T65DR doses. The subjects of the study are 75,991 members of the Life Span Study sample for whom DS86 doses have been calculated. This reevaluation of the exposures does not change the list of radiation-related cancers. Most differences in dose response between Hiroshima and Nagasaki are no longer significant with the DS86 doses. The dose-response curve is closer to linearmore »« less
https://doi.org/10.2307/3577409
Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system

Journal Article Otake, M; Schull, W - Radiation Research; (USA)

This paper investigates the quantitative relationship of ionizing radiation to the occurrence of posterior lenticular opacities among the survivors of the atomic bombings of Hiroshima and Nagasaki suggested by the DS86 dosimetry system. DS86 doses are available for 1983 (93.4%) of the 2124 atomic bomb survivors analyzed in 1982. The DS86 kerma neutron component for Hiroshima survivors is much smaller than its comparable T65DR component, but still 4.2-fold higher (0.38 Gy at 6 Gy) than that in Nagasaki (0.09 Gy at 6 Gy). Thus, if the eye is especially sensitive to neutrons, there may yet be some useful information onmore »« less
https://doi.org/10.2307/3577557
Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987

Journal Article Thompson, D; Soda, Midori; Izumi, Shizue; ... - Radiation Research; (United States)

This report presents, for the first time, comprehensive data on the incidence of solid cancer and risk estimates for A-bomb survivors in the extended Life Span Study (LSS-E85) cohort. Among 79,972 individuals, 8613 first primary solid cancers were diagnosed between 1958 and 1987. As part of the standard registration process of the Hiroshima and Nagasaki tumor registries, cancer cases occurring among members of the LSS-E85 cohort were identified using a computer linkage system supplemented by manual searches. Special efforts were made to ensure complete case ascertainment, data quality and data consistency in the two cities. For all sites combined, 75%more »« less
https://doi.org/10.2307/3578892

Similar Records